Form 4: SI-BONE Executive Sells Shares to Cover Tax Obligations and Under 10b5-1 Plan

Anthony J. Recupero, President of Commercial Operations at SI-BONE, Inc., sold shares to cover tax obligations and under a pre-arranged 10b5-1 trading plan.

Summary

• Anthony J. Recupero, President of Commercial Operations at SI-BONE, Inc., sold a total of 5,937 shares of common stock.
• The sales occurred on November 18, 2024, and November 19, 2024.
• The sales on November 18 were to cover tax withholding obligations related to the vesting of restricted stock units.
• The sale on November 19 was executed under a pre-arranged 10b5-1 trading plan.
• The weighted average sale prices ranged from $12.1713 to $12.9279 per share.
• Following these transactions, Recupero beneficially owns 226,484 shares of SI-BONE common stock, including 129,685 shares issuable on settlement of restricted stock units.

Sentiment

Score: 5

Explanation: The document reflects routine insider trading activity for tax purposes and under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine filing related to insider trading activity and is common for executives who receive stock-based compensation. The use of 10b5-1 plans is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the medical device industry like SI-BONE.
• Similar filings are regularly seen from executives at companies such as Medtronic, Stryker, and Zimmer Biomet, reflecting routine stock transactions for tax and diversification purposes.
• The price range of the transactions is within the typical trading range for the company's stock, and the volume of shares sold is not unusual for an executive's stock-based compensation.

Stakeholder Impact

• The stock sales by the executive may have a minor impact on the stock price, but the transactions are not expected to significantly affect the company's operations or long-term prospects.
• Shareholders may view the sales as routine and not indicative of any negative sentiment from the executive.

Key Dates

Keywords

SI-BONE, insider trading, Form 4, stock sale, 10b5-1 plan, restricted stock units, tax withholding, executive compensation